Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies919
ViewRay
ViewRay develops advanced radiation therapy technology for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
Radixact
Accuray's Radixact provides precise cancer treatment with minimal damage to healthy tissue.
Sector
Subsector
Keywords
Location
Accuray
Accuray is a biomedical company that provides medical practices with tumor treatment solutions.
Sector
Subsector
Location
total rounds
total raised
Advanced Oncotherapy
Advanced Oncotherapy provides advanced radiotherapy systems for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 30.11.2000. Their latest investor Avalon Ventures. Their latest round Venture - Series Unknown
Avalon Ventures
Avalon Ventures is a venture capital firm focused on information technology and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Venture Investors
Venture Investors is a Midwest-based venture capital firm that invests in innovative ideas that shape the future of health and wellness.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors3
Number of lead investors
Number of investors
Avalon Ventures
Avalon Ventures is a venture capital firm focused on information technology and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Venture Investors
Venture Investors is a Midwest-based venture capital firm that invests in innovative ideas that shape the future of health and wellness.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
John Neis
John is managing director of Venture Investors, an early-stage venture capital firm focused on opportunities emerging from leading research universities in the Midwest. He currently serves on the Board of Directors at Cellectar, Inc., Deltanoid Pharmaceuticals, Inc., the Wisconsin Technology Council and is a science and technology advisor to Wisconsin’s governor and legislature. He serves on the Dean’s Advisory Board, the Advisory Board of the Weinert Applied Ventures Program in the School of Business and the Tandem Press Advisory Board in the School of Education at the University of Wisconsin–Madison. He graduated Magna Cum Laude with a BS in finance from the University of Utah and received an MS in marketing and finance from the University of Wisconsin–Madison. He is a chartered financial analyst.
current job
organization founded
Advantage Capital
Advantage Capital is a venture capital firm specializing in growth equity and debt investments.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
People
Founders1
Thomas "Rock" Mackie
T. "Rock" Mackie PhD, is co-founder and Chairman at HealthMyne, an imaging informatics company. Rock is a Director of Medical Devices (part-time) at the Mortgridge Institute for Research in Madison and Emeritus Professor in the departments of Medical Physics, Human Oncology, and Engineering Physics at the UW-Madison. In 1997, Rock co-founded TomoTherapy Inc., which developed an innovative, integrated hardware/software system for accurate, image-guided radiation treatment delivery. TomoTherapy’s initial public offering in 2007 reached a peak market capitalization of over $1.2 B under Rock’s leadership as chairman of the board of directors. Prior to its sale to Accuray, TomoTherapy’s cumulative revenues exceeded $ 1 billion. In 1992, Rock co-founded Geometrics, a HCIT company which developed the PinnacleTM Radiation Treatment Planning (RTP) system, now marketed by Philips Medical Systems. From 1996 until 2012, Pinnacle generated over $350 M in revenues and achieved a 45+% global market share. He has more than 150 publications and over 30 inventions with issued US patents.
current job
count Of Investments
Thomas "Rock" Mackie
Employee Profiles73
Michael Hunsucker
Sales manager - fl and public relations
Frederick Robertson
Chief Executive Officer and Director